Table 5.
Treatment-related adverse events.
Eltrombopag (N=51) | rhTPO (N=50) | |
---|---|---|
Any AE, n (%) | 7 (13.7) | 6 (12.0) |
Elevated transaminase | 3 (5.9) | 0 (0.0) |
Hyperbilirubinemia | 1 (2.0) | 0 (0.0) |
Fever | 1 (2.0) | 2 (4.0) |
Fatigue | 1 (2.0) | 1 (2.0) |
Dizziness | 1 (2.0) | 1 (2.0) |
Diarrhea | 0 (0.0) | 1 (2.0) |
Muscle aches | 0 (0.0) | 1 (2.0) |